RE:RE:Panama is right about the small burn rateYou're right about everything but the need for a buyout, and maybe even the need for financing. The previous financing was done because they wanted some extra money, not because they needed the whole amount. They realized the market was not favourable at that time to wait out the financing so, like we should expect responsible management to do, they canceled it so as not to put shareholders in a crappy situation.
We've already heard GEN is deep in negotiations: multiple meetings with multiple healthcare providers. You don't have multiple meetings without significant interest and I have a feeling contract news could be imminent (in my world "imminent" could mean days to a month or two). So everything you describe below should come down the pipe WITHOUT a buyout, and maybe even without financing. Reread the highlighted bits and let that sink in for a bit...what do you think the sp will be when all that happens?? :)
goldbug83 wrote: You know I've been thinking that maybe T.GEN needs to be bought out by a larger company with a war chest to deploy. Get testing all across USA, maybe a heavy marketing campaign, some national exposure, a huge industry sales force, open regional labs across the country. They could completely corner the market. It’s such an easy sell to the public, saves Medicare money for the US government and all with an ever growing baby boomer population. It’s just a matter of figuring out what is T.GEN worth at present value in a buy-out scenario. This company has huge cash flow potential. Thoughts?